ObvioHealth, a Virtual Research Organization (VRO) that is currently leading the long-overdue digitization of health innovation, has come forward to talk about remote clinical trial monitoring and how the COVID-19 pandemic has accelerated its adoption and normalization.
Remote clinical trials aren’t exactly new technology. The FDA had suggested that the industry shift to remote monitoring as far back as 2013. Unfortunately, the industry was slower than anticipated to adopt the practice. COVID-19 was the catalyst that caused mass adoption of this more efficient clinical trial model.
But the pandemic wasn’t the only reason for this mass adoption; it also makes a lot of sense. One of the biggest benefits is the trial monitor’s ability to access trial and patient information from anywhere at any time. Remote access allows monitors to complete trial management tasks without needing to travel or wait for feedback. This not only saves time, but also costs.
A study’s progress can be tracked in real time. Instead of following the traditional paper-based clinical trial methodology, remote monitoring is entirely digital and allows for site performance and study progress to be tracked without staff intervention. Monitors can usually configure a system for alerts and notifications when specific actions are completed, such as document completion or other activities.
ObvioHealth launched their platform way back in 2017, and since then it has been leveraging the industry’s massive technological innovation to tackle the current inefficiencies that are present within the entire clinical trial process. The company’s current successes come from the fusion of experienced clinical researchers and pioneering health technologists combined into one, which is what they consider to be their winning formula for a much more seamless clinical trial process.
Readers who are interested in clinical trials or simply want to find out what else ObvioHealth can bring to the table, see their website: https://www.obviohealth.com/
ObvioHealth USA, Inc.
ObvioHealth USA, Inc.
3452 Lake Lynda Drive Suite 151
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Fortune Outlook journalist was involved in the writing and production of this article.